Conference · London, United Kingdom
Biosimilars - Commercial Strategies and Regulatory Guidelines
Pharmaceuticals · Biology
Key numbers
- Editions on record
- 1first in 2013
About Biosimilars - Commercial Strategies and Regulatory Guidelines
Biosimilar markets are increasingly attracting more interest and are seen as a new industry for some generic companies to exploit, as these companies attempt to adjust to the high competition and low profit margins found in the commodity generics market. Less regulated markets have seen biosimilars take off in recent years; however this is not the case across Europe and the US where regulatory barriers have slowed the development of this industry in these markets.
SMi's masterclass hosted by Interpharm Consultancy, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US. Case study led and extremely informative, Peter Wittner looks to help identify both successful and unsuccessful applications in regards to biosimilar regulatory approval in a bid to better inform attendees of how they might approach.
Contact Fateja Begum
Tel: +44 (0) 20 7827 6184
Email: fbegum@smi-online.co.uk
Category: Conferences
Price: £599
Time: 8:50 am - 1:00 pm
Speaker: Peter Wittner
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2013 | 9 Dec 2013 | Holiday Inn London Bloomsbury London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Biosimilars - Commercial Strategies and Regulatory Guidelines?
The next dates haven't been confirmed. The last edition we have on record was 9 Dec 2013.
Where is it held?
The last edition we have was at Holiday Inn London Bloomsbury, London, United Kingdom.